Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
4D Molecular Therapeutics
Biotech
Adverum's gene therapy reduces treatment burden in wet AMD
Adverum’s ixo-vec, a gene therapy for wet AMD, has demonstrated a reduction in treatment burden and maintained visual acuity in a phase 2 study.
Gabrielle Masson
Feb 8, 2024 11:17am
4DMT links gene therapy to drop in Eylea injections
Feb 5, 2024 6:23am
4DMT gets closer to lifting FDA hold on Fabry disease program
Oct 30, 2023 12:29pm
Madrigal snags Sanofi exec as CEO—Chutes & Ladders
Sep 15, 2023 9:30am
Astellas to test out 4DMT's eye disease gene therapy vector
Jul 10, 2023 7:30pm
FDA slaps hold on 4DMT's phase 1/2 gene therapy trial
Feb 3, 2023 1:28pm